Organizers: National Association for Enteral and Parenteral Nutrition-NUPENS, Section for Nutrition, Microbiota and Immunometabolism SLD, Section for Internal Medicine SLD, Association of Gastroenterologists of Serbia-Section of Young Gastroenterologists, South-East European Biologic & Regenerative Medicine Association-SEEBRA, Association Med- compass, Medical Chamber of Montenegro youth branch.
Read more HERE.
The FDA has approved a clinical trial to study COVID-19 patients administered with umbilical cord-derived mesenchymal stem cells, which should prevent lung inflammation. The project leader is Dr Camillo Ricordi, study base: University of Miami Health System and Jackson Health System, Miami.
Read more HERE
Virtual international press conference
Participants on the conference were experts from Slovenia, US and India as a
consortium frequently involved in the production of stem cells. One of the
participants also was an Italian doctor who applied stem cell therapy in Udine.
Clinical studies are fast track approved in China, America, Japan, Israel.
Watch the whole press conference HERE
An international group of experts has successfully implemented new therapy in the first seven COVID-19 patients. All patients treated with stem cells survived. This type of therapy has already been successfully used for other serious immune diseases.
The first results were released this month. Such results are a hope for the ability of biological therapies to combat the COVID-19 pandemic.
An international group of experts has successfully applied new therapy to the first seven COVID-19 patients. All patients treated with a specific type of stem cell survived. Successful treatment of these patients, with an international consortium of experts, was performed at Beijing YouAn Hospital, Capital Medical University, China, with the approval and protocols of the Chinese Center for Disease Control and Prevention and the National Health Commissionof China.